During the past decade, Randolph Medical Associates conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Randolph Medical Associates" #1 sponsor was "Bayer" with 2 trials, followed by "Kowa Research Institute, Inc." with 1 trials sponsored, "Novartis Pharmaceuticals" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Sucampo Pharma Americas, LLC" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Randolph Medical Associates" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator and "Translational Research in Oncology" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Randolph Medical Associates" are "Type 2 Diabetes Mellitus" (3 trials), "Chronic Kidney Disease" (2 trials), "Dyslipidemia" (1 trials), "Early Breast Cancer" (1 trials) and "Opioid-Induced Bowel Dysfunction" (1 trials). Many other conditions were trialed in "Randolph Medical Associates" in a lesser frequency.

Most popular intervention types in "Randolph Medical Associates" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Empagliflozin" (1 trials), "Endocrine Therapy" (1 trials), "Finerenone (Kerendia, BAY94-8862 )" (1 trials) and "Finerenone (Kerendia, BAY94-8862)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Randolph Medical Associates" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Randolph Medical Associates". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Randolph Medical Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Randolph Medical Associates, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Randolph Medical Associates has several departments that took part in Clinical trials: "Randolph Health Internal Medicine" - 3 trials